Intellia Therapeutics
NTLA
NTLA
85 hedge funds and large institutions have $269M invested in Intellia Therapeutics in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 76 → 85 (+9)
0.19% more ownership
Funds ownership: 46.47% → 46.66% (+0.19%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
85
Holding in Top 10
1
Calls
$1.2M
Puts
$778K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$4.28M | |
| 3 | +$1.52M | |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$1.48M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.48M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$4.66M | |
| 3 | -$4.23M | |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$2.11M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.28M |